Bioactive Milk Peptides and Blood Pressure

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01031485

Enrollment

Unknown

Registered

2009-12-14

Start date

2010-01-31

Completion date

2010-08-31

Last updated

2014-12-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stage 1 Hypertension

Keywords

hypertension, blood pressure, milk peptides, bioactive peptides, randomized controlled trial

Brief summary

The purpose of this study is to investigate the effects of bioactive milk peptides on blood pressure in mildly hypertensive subjects.

Interventions

DIETARY_SUPPLEMENTMilk peptides and plant sterols

OTHERPlacebo

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Masking

DOUBLE

Eligibility

Sex/Gender

ALL

Age

30 Years to 60 Years

Inclusion criteria

* age 30-60 years * systolic blood pressure 140-160 mmHg and diastolic blood pressure 90-99 mmHg in office measurement * apparently healthy

Exclusion criteria

* antihypertensive and lipid-lowering drugs * unstable coronary artery disease, diabetes, malignant diseases, secondary hypertension * BMI \> 32 kg/m2 * milk allergy * smoking * alcohol abuse * pregnancy, lactation * simultaneous participation in other clinical trial

Design outcomes

Primary

Measure	Time frame
Blood pressure	—

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026